REGN
Regeneron Pharmaceuticals, Inc. · Healthcare · Biotechnology
TECHSellZACKSHold
R500#286 today
$735.20
+0.05% today · -6.71% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- REGN +0.05% on the last session vs SPY +0.74%: −0.7 pts of stock-specific move.
- Aftermath, big drop (Sep 28): After its 60 big drops in the past 5 years, REGN typically gained 1.4% over the next month (median) and was higher 58% of the time; half the outcomes fell between -4.6% and +5.9%. An ordinary month: +1.1%. Among S&P 500 stocks after big drops, that ranks #275 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Key facts
- Market cap
- $75.7B
- Held by institutions
- 93.5%
- Short interest
- 2.6%
- 52-week range
- 541.00–859.34
- Analyst mean target
- —
- Next earnings
- Oct 30 BMO
- Forward P/E
- 12.0
Recent events
Earnings ▲
2Q2026 results: EPS $14.29 vs $10.21 expected beat +$4.08 (+40.0%); revenue $4.3B; next session +6.2% (+4.5 vs SPY)Earnings ▲
1Q2026 results: EPS $9.47 vs $8.90 expected beat +$0.57 (+6.4%); revenue $3.6B; next session -6.2% (-6.2 vs SPY)Earnings ▲
4Q2025 results: EPS $11.44 vs $10.75 expected beat +$0.69 (+6.4%); revenue $3.9B; next session -1.1% (-0.8 vs SPY)Earnings ▲
3Q2025 results: EPS $11.83 vs $9.64 expected beat +$2.19 (+22.7%); revenue $3.8B; next session +11.8% (+11.6 vs SPY)